Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Business news from the Chicago Tribune. The latest reporting on business, real estate and transportation in Chicagoland.

Full-flex and part-time options are available to domestic students only. International students are eligible to apply for the full-time option, available in Fall only. The Rutgers Business School ...